Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice

Archive ouverte

Boveda, Serge | Narayanan, Kumar | Jacob, Sophie | Providencia, Rui | Algalarrondo, Vincent | Bouzeman, Abdeslam | Beganton, Frankie | Defaye, Pascal | Cécile Perier, Marie | Sadoul, Nicolas | Piot, Olivier | Klug, Didier | Gras, Daniel | Fauchier, Laurent | Bordachar, Pierre | Babuty, Dominique | Deharo, Jean-Claude | Leclercq, Christophe | Marijon, Eloi

Edité par CCSD ; Wiley -

International audience. Background Technology and clinical practice surrounding the use of the primary prevention implantable cardioverter defibrillator (ICD) are in a state of constant evolution. The purpose of the study was to test the hypothesis of significant temporal trends in characteristics and outcomes over a decade of ICD therapy. Methods Between 2002 and 2012, 5,539 consecutive patients (age 62.5 ± 11 years, 84.9% male), with ischemic or nonischemic cardiomyopathy, implanted with a primary prevention ICD from 12 centers in France were included. Information on characteristics and outcomes (including causes of death) were evaluated over a median follow-up of 994 days (466-1,667). Results In addition to a shift in the type of devices implanted with a significant increase in cardiac resynchronization therapy-defibrillator (CRT-D) over time (43.6 to 60.4%, P = 0.0001), an increase in mean age (from 61.5 ± 11.6 to 63.2 ± 10.9 years, P = 0.0016), proportion of nonischemic cardiomyopathy (31.0 to 44.7%, P <0.0001) and women recipients (11.4 to 15.8%, P = 0.004) was observed. A total of 1,181 patients (22.3%) received ≥1 appropriate therapy, inappropriate therapies occurred in 355 patients (6.7%) and 826 patients (15.2%) died, mainly from cardiovascular causes (49.3%). Annual mortality incidence (5.4% to 4.3%, P = 0.05), as well as incidence of appropriate therapy (10.4% to 7.1%, P = 0.0004), significantly decreased over the decade. By contrast, incidence of ICD-related late (>30 days after implant) complications significantly increased (4.6 to 7.6%, P = 0.003). Conclusion Our findings demonstrate significant changes in patterns of use and outcomes in primary prevention ICD over the last decade with reductions in mortality and appropriate therapies, counterbalanced by an increase in complications.

Suggestions

Du même auteur

Comparison of Outcome of Possible Versus Definite Infective Endocarditis Involving Native Heart Valves

Archive ouverte | Boveda, Serge | CCSD

International audience

Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world: Main findings from the French multicentre DAI-PP programme (pilot phase). Implantation des défibrillateurs en prévention primaire dans la vraie vie: les principaux résultats de la phase pilote du programme DAIPP

Archive ouverte | Boveda, Serge | CCSD

International audience. This review summarizes the main findings of the French multicentre DAI-PP pilot programme, and discusses the related clinical and research perspectives. This project included retrospectively ...

Outcome of Primary Prevention Implantable Cardioverter Defibrillator Therapy According to New York Heart Association Functional Classification

Archive ouverte | Providencia, Rui | CCSD

International audience. We aimed to assess if the outcome of primary prevention implantable cardioverter defibrillators (ICDs) without cardiac resynchronization therapy is dependent on New York Heart Association (NY...

Chargement des enrichissements...